Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy.
Kinnaird T, Butt M, Abdul F, Yazji K, Hailan A, Gallagher S, Ossei-Gerning N, Chase A, Choudhury A, Smith D, Anderson R. Kinnaird T, et al. Among authors: choudhury a. PLoS One. 2016 Jun 30;11(6):e0157812. doi: 10.1371/journal.pone.0157812. eCollection 2016. PLoS One. 2016. PMID: 27362841 Free PMC article.
Twelve-month outcomes of patients unsuitable for prolonged DAPT presenting with an acute coronary syndrome and treated with polymer-free biolimus A9 drug-coated stents.
Kinnaird T, Abdul F, Hailan A, Sheikh A, Hinton J, Yazji K, Elangovan S, Yousef A, Gallagher S, Choudhury A, Anderson R, O'Kane P, Smith D. Kinnaird T, et al. Among authors: choudhury a. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1220-1228. doi: 10.1002/ccd.27722. Epub 2018 Sep 23. Catheter Cardiovasc Interv. 2018. PMID: 30244504
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S, Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW; TALENT trial investigators. Zaman A, et al. Among authors: choudhury a. Lancet. 2019 Mar 9;393(10175):987-997. doi: 10.1016/S0140-6736(18)32467-X. Epub 2019 Feb 28. Lancet. 2019. PMID: 30827782 Clinical Trial.
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial.
Gao C, Kogame N, Sharif F, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Zaman A, de Winter RJ, Onuma Y, Serruys PW. Gao C, et al. Among authors: choudhury a. Circ Cardiovasc Interv. 2021 Mar;14(3):e010312. doi: 10.1161/CIRCINTERVENTIONS.120.010312. Epub 2021 Mar 9. Circ Cardiovasc Interv. 2021. PMID: 33685213 No abstract available.
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.
de Winter RJ, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits PC, Tonino PAL, Hofma SH, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys PW. de Winter RJ, et al. Among authors: choudhury a. EuroIntervention. 2022 Aug 19;18(6):492-502. doi: 10.4244/EIJ-D-21-00766. EuroIntervention. 2022. PMID: 35285804 Free PMC article. Clinical Trial.
Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
Carande EJ, Protty MB, Verhemel S, Hussein MH, Raman AS, UlHaq Z, Bundhoo S, Cullen J, Ionescu A, Choudhury A, Hussain HI, Hailan A. Carande EJ, et al. Among authors: choudhury a. Catheter Cardiovasc Interv. 2022 Oct;100(4):585-592. doi: 10.1002/ccd.30400. Epub 2022 Sep 14. Catheter Cardiovasc Interv. 2022. PMID: 36104863
1,646 results